Skip to content

Clinical trials

Phase 3 Memory Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Memory Disorders Phase: Phase 3 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20081
20091
20131
20151
20161
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medivation, Inc.2
AZTherapies, Inc.1
Baylor College of Medicine1
Eisai Inc.1
Forest Laboratories1
National Center for Complementary and Integrative Health (NCCIH)1
National Institute on Aging (NIA)1
University of California, Los Angeles1
University of Pennsylvania1
Wake Forest University Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Memory Disorders11
Alzheimer Disease7
Dementia5
Cognitive Dysfunction4
Neurodegenerative Diseases2
Brain Injuries1
Brain Injuries, Traumatic1
Breast Neoplasms1
Chronobiology Disorders1
Dementia, Vascular1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.